Morgan Stanley’s Health In Tech Inc HIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$972 Sell
962
-13,747
-93% -$17.1K ﹤0.01% 7515
2026
Q1
$21.3K Buy
+14,709
New +$21.4K ﹤0.01% 6702
2025
Q4
Sell
-9,076
Closed -$29.1K 8546
2025
Q3
$29.1K Buy
+9,076
New +$21.7K ﹤0.01% 6576
2025
Q2
Sell
-25,630
Closed -$17K 8327
2025
Q1
$17K Buy
+25,630
New +$123K ﹤0.01% 6631

Other funds holding HIT

Morgan Stanley's HIT Position: Q2 2026 in Review

Morgan Stanley reduced its Health In Tech Inc (HIT) stake by 93% in Q2 2026, selling an estimated $17.1K and leaving 962 shares worth $972. The position accounts for ﹤0.01% of the portfolio, ranked #7515.

Morgan Stanley first reported a position in HIT in Q1 2025 and has held it in 4 quarters since. The position peaked at $29.1K in Q3 2025. 21 funds tracked by Wall St. Rank hold HIT as of Q2 2026.

  • Morgan Stanley held 962 shares of Health In Tech Inc worth $972 as of Q2 2026.
  • Morgan Stanley sold 13,747 Health In Tech Inc shares in Q2 2026, an estimated $17.1K.
  • Health In Tech Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7515 holding.
  • Morgan Stanley first reported a position in Health In Tech Inc in Q1 2025 and has held it in 4 quarters since.
  • Morgan Stanley's Health In Tech Inc position peaked at $29.1K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Health In Tech Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.